Elanco Animal Health Incorporated
NYSE:ELAN
12.28 (USD) • At close May 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 4,439 | 4,417 | 4,418 | 4,765 | 3,273.3 | 3,071 | 3,066.8 | 2,889 | 2,913.5 | 2,909.1 |
| Cost of Revenue
| 2,530 | 2,479 | 1,913 | 2,134 | 1,666.6 | 1,470.3 | 1,573.8 | 1,493.9 | 1,409 | 1,533.7 |
| Gross Profit
| 1,909 | 1,938 | 2,505 | 2,631 | 1,606.7 | 1,600.7 | 1,493 | 1,395.1 | 1,504.5 | 1,375.4 |
| Gross Profit Ratio
| 0.43 | 0.439 | 0.567 | 0.552 | 0.491 | 0.521 | 0.487 | 0.483 | 0.516 | 0.473 |
| Reseach & Development Expenses
| 344 | 327 | 321 | 369 | 327 | 270.1 | 246.6 | 251.7 | 265.8 | 291 |
| General & Administrative Expenses
| 0 | 1,073 | 1,065 | 1,156 | 0 | 0 | 735.2 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 207 | 201 | 248 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 1,314 | 1,285 | 1,266 | 1,404 | 996.6 | 760.2 | 735.2 | 779.8 | 784.8 | 916 |
| Other Expenses
| 0 | 0 | 528 | 556 | 359.9 | 200.4 | -41.3 | 0.1 | 2.8 | -1.6 |
| Operating Expenses
| 1,658 | 1,612 | 2,115 | 2,329 | 1,683.5 | 1,230.7 | 1,179.2 | 1,252.7 | 1,221.3 | 1,370 |
| Operating Income
| 251 | 326 | 358 | 297 | 101.5 | 342.6 | 313.8 | 142.4 | 283.2 | 5.4 |
| Operating Income Ratio
| 0.057 | 0.074 | 0.081 | 0.062 | 0.031 | 0.112 | 0.102 | 0.049 | 0.097 | 0.002 |
| Total Other Income Expenses Net
| 237 | -1,521 | -456 | -875 | -590 | -291.8 | -199.7 | -375 | -305.6 | -264.9 |
| Income Before Tax
| 488 | -1,195 | -66 | -567 | -672 | 78.2 | 114.1 | -232.6 | -22.4 | -259.5 |
| Income Before Tax Ratio
| 0.11 | -0.271 | -0.015 | -0.119 | -0.205 | 0.025 | 0.037 | -0.081 | -0.008 | -0.089 |
| Income Tax Expense
| 150 | 36 | 8 | -95 | -111.9 | 10.3 | 27.6 | 78.1 | 25.5 | -48.7 |
| Net Income
| 338 | -1,231 | -74 | -472 | -560.1 | 67.9 | 86.5 | -310.7 | -47.9 | -210.8 |
| Net Income Ratio
| 0.076 | -0.279 | -0.017 | -0.099 | -0.171 | 0.022 | 0.028 | -0.108 | -0.016 | -0.072 |
| EPS
| 0.68 | -2.5 | -0.15 | -0.97 | -1.27 | 0.18 | 0.28 | -0.87 | -0.13 | -0.59 |
| EPS Diluted
| 0.68 | -2.5 | -0.15 | -0.97 | -1.27 | 0.18 | 0.28 | -0.87 | -0.13 | -0.59 |
| EBITDA
| 1,489 | -224 | 866 | 409 | -76.8 | 471.6 | 439.7 | 85.8 | 232 | 242.3 |
| EBITDA Ratio
| 0.335 | -0.051 | 0.196 | 0.086 | -0.023 | 0.154 | 0.143 | 0.03 | 0.08 | 0.083 |